absolutely BMS 213 (Daklinza 30 mg) Generic Name: daclatasvir Pill with imprint BMS 213 is Green, Five-sided and has been identified as Daklinza 30 mg. It is supplied by Bristol-Myers Squibb Company. Daklinza is used in the treatment of hepatitis c and belongs to the drug class NS5A inhibitors. Daklinza 30 mg is not a controlled substance under the Controlled Substance Act (CSA). Images for BMS 213 Save up to 80% off prescription medications Click here for your free Discount Card Daklinza Generic Name: daclatasvir Imprint: BMS 213 Strength: 30 mg Color: Green Shape: Five-sided Availability: Prescription only Drug Class: NS5A inhibitors CSA Schedule: Not a controlled drug Labeler / Supplier: Bristol-Myers Squibb Company National Drug Code (NDC): 00003-0213 More info Imprint Search Print Get help with Imprint Code FAQs . Print this page Add to My Med List More about Daklinza (daclatasvir) Side Effects During Pregnancy Dosage Information Drug Images Drug Interactions Support Group Pricing & Coupons En Español 10 Reviews Add your own review/rating Drug class: NS5A inhibitors Consumer resources Daklinza Daklinza (Advanced Reading) Professional resources Daklinza (AHFS Monograph) Daklinza (FDA) Related treatment guides Hepatitis C Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist. Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved. Drug Status Rx Availability Prescription only N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Daklinza Rating 10 User Reviews 9.8 /10 10 User Reviews 9.8 Rate it! Drug Class NS5A inhibitors latest
did you know BMS 213 (Daklinza 30 mg) unique
EmoticonEmoticon